285 related articles for article (PubMed ID: 19179471)
21. Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of alpha beta-TCR+ and CD4+ cells negates the effect.
Ildstad ST; Chilton PM; Xu H; Domenick MA; Ray MB
Blood; 2005 Mar; 105(6):2577-84. PubMed ID: 15498851
[TBL] [Abstract][Full Text] [Related]
22. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
[TBL] [Abstract][Full Text] [Related]
23. Distinct requirements for achievement of allotolerance versus reversal of autoimmunity via nonmyeloablative mixed chimerism induction in NOD mice.
Nikolic B; Onoe T; Takeuchi Y; Khalpey Z; Primo V; Leykin I; Smith RN; Sykes M
Transplantation; 2010 Jan; 89(1):23-32. PubMed ID: 20061915
[TBL] [Abstract][Full Text] [Related]
24. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants.
Fischbein MP; Ardehali A; Yun J; Schoenberger S; Laks H; Irie Y; Dempsey P; Cheng G; Fishbein MC; Bonavida B
J Immunol; 2000 Dec; 165(12):7316-22. PubMed ID: 11120867
[TBL] [Abstract][Full Text] [Related]
25. TLR agonists prevent the establishment of allogeneic hematopoietic chimerism in mice treated with costimulation blockade.
Miller DM; Thornley TB; Pearson T; Kruger AJ; Yamazaki M; Shultz LD; Welsh RM; Brehm MA; Rossini AA; Greiner DL
J Immunol; 2009 May; 182(9):5547-59. PubMed ID: 19380803
[TBL] [Abstract][Full Text] [Related]
26. Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4(+) T lymphocytes.
Ahmed A; Mukherjee S; Nandi D
Immunology; 2009 Mar; 126(3):363-77. PubMed ID: 18710402
[TBL] [Abstract][Full Text] [Related]
27. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
[TBL] [Abstract][Full Text] [Related]
28. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
Taylor PA; Noelle RJ; Blazar BR
J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
[TBL] [Abstract][Full Text] [Related]
29. Trogocytosis of CD80 and CD86 by induced regulatory T cells.
Gu P; Gao JF; D'Souza CA; Kowalczyk A; Chou KY; Zhang L
Cell Mol Immunol; 2012 Mar; 9(2):136-46. PubMed ID: 22307040
[TBL] [Abstract][Full Text] [Related]
30. Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.
Graca L; Daley S; Fairchild PJ; Cobbold SP; Waldmann H
BMC Immunol; 2006 Apr; 7():9. PubMed ID: 16638128
[TBL] [Abstract][Full Text] [Related]
31. Thymic medullary epithelium and thymocyte self-tolerance require cooperation between CD28-CD80/86 and CD40-CD40L costimulatory pathways.
Williams JA; Zhang J; Jeon H; Nitta T; Ohigashi I; Klug D; Kruhlak MJ; Choudhury B; Sharrow SO; Granger L; Adams A; Eckhaus MA; Jenkinson SR; Richie ER; Gress RE; Takahama Y; Hodes RJ
J Immunol; 2014 Jan; 192(2):630-40. PubMed ID: 24337745
[TBL] [Abstract][Full Text] [Related]
32. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
33. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH
J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874
[TBL] [Abstract][Full Text] [Related]
34. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.
Taylor PA; Lees CJ; Waldmann H; Noelle RJ; Blazar BR
Blood; 2001 Jul; 98(2):467-74. PubMed ID: 11435318
[TBL] [Abstract][Full Text] [Related]
35. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
[TBL] [Abstract][Full Text] [Related]
36. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
37. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation.
Umemura A; Morita H; Li XC; Tahan S; Monaco AP; Maki T
J Immunol; 2001 Sep; 167(6):3043-8. PubMed ID: 11544287
[TBL] [Abstract][Full Text] [Related]
38. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade.
Pilat N; Klaus C; Schwarz C; Hock K; Oberhuber R; Schwaiger E; Gattringer M; Ramsey H; Baranyi U; Zelger B; Brandacher G; Wrba F; Wekerle T
Am J Transplant; 2015 Jun; 15(6):1568-79. PubMed ID: 25783859
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
